Inflammation Case Studies
A study published in the Journal of Immunological Methods evaluated nine technology platforms and four cytokine immunoassays (IL-6, TNFα, IL-17a, IL-2), looking at assay precision, sensitivity, parallelism and data correlation, highlighting Simoa's capabilities.
At the inaugural Powering Precision Health Summit 2016, Dennis Ausiello, MD, Massachusetts General Hospital Emeritus, presented a keynote address highlighting advancements in the inflammatory space.
Simoa By The Numbers
Quanterix' digital health solution, Simoa, is changing the way researchers, academics and drug manufacturers measure and predict a range of inflammatory disease. Quanterix' focus in inflammation is growing with a network of academic researchers and pharmaceutical and biotech partners. Learn about Simoa's application in inflammation by exploring our scientific publications and journals.